BAP1 and mesothelioma: To test the efficacy of our drug combination in vivo, we transplanted the human mesothelioma cell lines NCI-H226 and its isogenic counterpart NCI-H226 + BAP1 WT into NOD-Scid IL2Rγnull mice.